Kiromic Biopharma Inc. (KRBP): Price and Financial Metrics
GET POWR RATINGS... FREE!
KRBP Stock Price Chart Interactive Chart >
KRBP Price/Volume Stats
| Current price | $0.21 | 52-week high | $1.11 |
| Prev. close | $0.22 | 52-week low | $0.15 |
| Day low | $0.20 | Volume | 5,005,408 |
| Day high | $0.22 | Avg. volume | 2,019,021 |
| 50-day MA | $0.22 | Dividend yield | N/A |
| 200-day MA | $0.35 | Market Cap | 4.29M |
Kiromic Biopharma Inc. (KRBP) Company Bio
Kiromic Biopharma, Inc. operates as a biotechnology company, which engages in the development of cancer engineered immunotherapies. Its technologies include Intelligent Immunotherapy, Diamond AI, CancerSplice, ABBIE, and CAR-T Proprietary Binder Technology. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Latest KRBP News From Around the Web
Below are the latest news stories about KIROMIC BIOPHARMA INC that investors may wish to consider to help them evaluate KRBP as an investment opportunity.
Mind-blowing stocks: Alphabet Inc. (NASDAQ:GOOGL 0.58%), Kiromic BioPharma, Inc. (NASDAQ:KRBP 7.04%)GOOGL has seen its SMA50 which is now 6.01%. In looking the SMA 200 we see that the stock has seen a -7.32%. KRBP has seen its SMA50 which is … The post Mind-blowing stocks: Alphabet Inc. (NASDAQ:GOOGL 0.58%), Kiromic BioPharma, Inc. (NASDAQ:KRBP 7.04%) appeared first on Stocks Equity . |
Is Kiromic BioPharma Inc. (NASDAQ: KRBP) A Good Investment For New Investors Now?Kiromic BioPharma Inc. (NASDAQ:KRBP) shares, rose in value on Friday, 01/20/23, with the stock price up by 3.54% to the previous day’s close as strong demand from buyers drove the stock to $0.21. Actively observing the price movement in the last trading, the stock closed the session at $0.20, falling within a range of $0.2003 … Is Kiromic BioPharma Inc. (NASDAQ: KRBP) A Good Investment For New Investors Now? Read More » |
During The Past Six Months, Kiromic BioPharma Inc. (NASDAQ: KRBP) Shares Took An -48.64% Jump. Here Is What We Should ExpectDuring the recent session, Kiromic BioPharma Inc. (NASDAQ:KRBP)’s traded shares were 0.43 million. At the last check today, the stock’s price was $0.22, reflecting an intraday gain of 7.84% or $0.02. The 52-week high for the KRBP share is $1.27, that puts it down -477.27 from that peak though still a striking 31.82% gain since … During The Past Six Months, Kiromic BioPharma Inc. (NASDAQ: KRBP) Shares Took An -48.64% Jump. Here Is What We Should Expect Read More » |
Investing in Kiromic BioPharma Inc. (KRBP) might be a great opportunity, but the stock is a bit overvaluedAs of Tuesday, Kiromic BioPharma Inc.’s (NASDAQ:KRBP) stock closed at $0.22, up from $0.21 the previous day. While Kiromic BioPharma Inc. has overperformed by 3.52%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KRBP fell by -85.20%, with highs and lows ranging from $1.48 to $0.15, […] |
Kiromic BioPharma Arranges Up to $10 Million FinancingHOUSTON, October 27, 2022--Kiromic BioPharma, Inc. (NASDAQ: KRBP) ("Kiromic" or the "Company"), a clinical-stage fully-integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence and data mining platform to develop cell and gene therapies with a focus on immuno-oncology, announces it entered into a Standby Equity Purchase Agreement (the "SEPA") with YA II PN, LTD, a partnership managed by Yorkville Advisors Global LP, a global investment manager, to sell up to $8 mi |
KRBP Price Returns
| 1-mo | 16.21% |
| 3-mo | -28.81% |
| 6-mo | -43.26% |
| 1-year | -80.91% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 16.21% |
| 2022 | -88.19% |
| 2021 | -81.94% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...